Morphic Therapeutic (MORF) PT Lowered to $83 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Do Kim lowered the price target on Morphic Therapeutic (NASDAQ: MORF) to $83.00 (from $102.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
